Kyle Rose
Stock Analyst at Canaccord Genuity
(3.37)
# 950
Out of 4,876 analysts
114
Total ratings
53.26%
Success rate
13.81%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $30.22 | -10.66% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $313.08 | +3.49% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $393.55 | +10.53% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $58.60 | +21.16% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $31.78 | +123.41% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.19 | +55.04% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.95 | +412.82% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $11.08 | +98.56% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $86.33 | +73.75% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $7.61 | +3,447.96% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $18.43 | +46.50% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.97 | +661.42% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $10.50 | +42.86% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $181.75 | -32.87% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.63 | +10.19% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.77 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $91.46 | +36.67% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $30.22
Upside: -10.66%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $313.08
Upside: +3.49%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $393.55
Upside: +10.53%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $58.60
Upside: +21.16%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $31.78
Upside: +123.41%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.19
Upside: +55.04%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.95
Upside: +412.82%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $11.08
Upside: +98.56%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $86.33
Upside: +73.75%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $7.61
Upside: +3,447.96%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $18.43
Upside: +46.50%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.97
Upside: +661.42%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $10.50
Upside: +42.86%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $181.75
Upside: -32.87%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.63
Upside: +10.19%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.77
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $91.46
Upside: +36.67%